Atlas Trials

Flunarizine for Treatment Resistant Absence Epilepsy

Clinical trial NCT06153186 · TERMINATED

Trial details

NCT number
NCT06153186
Sponsor
University of British Columbia
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Childhood Absence EpilepsyJuvenile Absence EpilepsyJuvenile Myoclonic Epilepsy
Start date
2019-09-20
Primary completion
2023-05-26
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.